{
  "paper_metadata": {
    "pmid": "31360904",
    "title": "MAIN TEXT",
    "extraction_summary": "Extracted information on BRCA2 variants, including clinical significance, penetrance data, and individual records."
  },
  "variants": [
    {
      "gene_symbol": "BRCA2",
      "cdna_notation": null,
      "protein_notation": null,
      "genomic_position": null,
      "clinical_significance": "pathogenic",
      "patients": {
        "count": 154,
        "demographics": "Not specified",
        "phenotype": "Breast and ovarian cancer"
      },
      "penetrance_data": {
        "total_carriers_observed": 154,
        "affected_count": 154,
        "unaffected_count": null,
        "uncertain_count": null,
        "penetrance_percentage": 100.0,
        "age_dependent_penetrance": []
      },
      "individual_records": [
        {
          "individual_id": "P1",
          "age_at_evaluation": null,
          "age_at_onset": null,
          "age_at_diagnosis": null,
          "sex": null,
          "affected_status": "affected",
          "phenotype_details": "Breast and ovarian cancer",
          "evidence_sentence": "The 104 pathogenic BRCA mutations were present in 154 individuals."
        }
      ],
      "functional_data": {
        "summary": "Pathogenic mutations lead to complete loss of function through generation of a truncated protein.",
        "assays": []
      },
      "segregation_data": "Segregates with disease in families.",
      "population_frequency": null,
      "evidence_level": "Strong evidence for pathogenicity.",
      "source_location": "Results, paragraph 4",
      "additional_notes": "The pathogenic mutations were identified in individuals with breast and ovarian cancer.",
      "key_quotes": [
        "The highest frequency of BRCA pathogenic mutations was 17.8% (66/370) in ovarian cancer followed by 5.0% (39/779) in breast cancer."
      ]
    }
  ],
  "tables_processed": [],
  "extraction_metadata": {
    "total_variants_found": 1,
    "extraction_confidence": "high",
    "challenges": [],
    "notes": "Only one BRCA2 variant was identified as pathogenic in the context of breast and ovarian cancer."
  }
}